These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38138443)

  • 21. The novel anti-inflammatory activity of mcIRBP from
    Liao PY; Lo HY; Liu IC; Lo LC; Hsiang CY; Ho TY
    Food Funct; 2022 Feb; 13(3):1268-1279. PubMed ID: 35023522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
    Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
    Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical constituents and anti-inflammatory activities of Maqian (Zanthoxylum myriacanthum var. pubescens) bark extracts.
    Zhang HL; Gan XQ; Fan QF; Yang JJ; Zhang P; Hu HB; Song QS
    Sci Rep; 2017 Apr; 7():45805. PubMed ID: 28383530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and optimization of crocetin loaded PLGA nanoparticles against diabetic nephropathy via suppression of inflammatory biomarkers: a formulation approach to preclinical study.
    Yang X
    Drug Deliv; 2019 Dec; 26(1):849-859. PubMed ID: 31524015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice.
    Cui W; Li B; Bai Y; Miao X; Chen Q; Sun W; Tan Y; Luo P; Zhang C; Zheng S; Epstein PN; Miao L; Cai L
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E87-99. PubMed ID: 23132297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
    Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
    Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the Nrf2 Protein Modulator Salvianolic Acid A Alone or Combined with Metformin on Diabetes-associated Macrovascular and Renal Injury.
    Wu P; Yan Y; Ma LL; Hou BY; He YY; Zhang L; Niu ZR; Song JK; Pang XC; Yang XY; Du GH
    J Biol Chem; 2016 Oct; 291(42):22288-22301. PubMed ID: 27417135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephroprotective effect of Combretum micranthum G. Don in nicotinamide-streptozotocin induced diabetic nephropathy in rats: In-vivo and in-silico experiments.
    Kpemissi M; Potârniche AV; Lawson-Evi P; Metowogo K; Melila M; Dramane P; Taulescu M; Chandramohan V; Suhas DS; Puneeth TA; S VK; Vlase L; Andrei S; Eklu-Gadegbeku K; Sevastre B; Veerapur VP
    J Ethnopharmacol; 2020 Oct; 261():113133. PubMed ID: 32673708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis.
    Yang SM; Ka SM; Wu HL; Yeh YC; Kuo CH; Hua KF; Shi GY; Hung YJ; Hsiao FC; Yang SS; Shieh YS; Lin SH; Wei CW; Lee JS; Yang CY; Chen A
    Diabetologia; 2014 Feb; 57(2):424-34. PubMed ID: 24317792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prospective Ameliorative Role of Zinc Oxide Nanoparticles in STZ-Induced Diabetic Nephropathy in Rats: Mechanistic Targeting of Autophagy and Regulating Nrf2/TXNIP/NLRP3 Inflammasome Signaling.
    Abd El-Khalik SR; Nasif E; Arakeep HM; Rabah H
    Biol Trace Elem Res; 2022 Apr; 200(4):1677-1687. PubMed ID: 34241775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway.
    Ma L; Wu F; Shao Q; Chen G; Xu L; Lu F
    Drug Des Devel Ther; 2021; 15():3207-3221. PubMed ID: 34321869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring molecular docking with MM-GBSA and molecular dynamics simulation to predict potent inhibitors of cyclooxygenase (COX-2) enzyme from terpenoid-based active principles of
    Nayak A; Gadnayak A; Dash KT; Jena S; Ray A; Nayak S; Sahoo A
    J Biomol Struct Dyn; 2023 Dec; 41(20):10840-10850. PubMed ID: 36576262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Inflammatory Therapy Modulates Nrf2-Keap1 in Kidney from Rats with Diabetes.
    Arellano-Buendía AS; Tostado-González M; García-Arroyo FE; Cristóbal-García M; Loredo-Mendoza ML; Tapia E; Sánchez-Lozada LG; Osorio-Alonso H
    Oxid Med Cell Longev; 2016; 2016():4693801. PubMed ID: 26955430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.
    Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway.
    Wen Y; Liu Y; Huang Q; Liu R; Liu J; Zhang F; Liu S; Jiang Y
    Phytomedicine; 2022 Jan; 95():153856. PubMed ID: 34856477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
    Zhang C; Li Q; Lai S; Yang L; Shi G; Wang Q; Luo Z; Zhao R; Yu Y
    J Ethnopharmacol; 2017 Jun; 205():207-216. PubMed ID: 28501426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modeling of methyl-α-Neu5Ac analogues docked against cholera toxin--a molecular dynamics study.
    Blessy JJ; Sharmila DJ
    Glycoconj J; 2015 Feb; 32(1-2):49-67. PubMed ID: 25676314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of GSK3β/β-TrCP axis via PHLPP1 exacerbates Nrf2 degradation leading to impairment in cell survival pathway during diabetic nephropathy.
    Mathur A; Pandey VK; Kakkar P
    Free Radic Biol Med; 2018 May; 120():414-424. PubMed ID: 29655866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.